MGA Report Comes in at Number One at The Center for Biosimilars
MGA Report Comes in at Number One at The Center for Biosimilars The Center for Biosimilars has announced that MGA’s recent report, “How Patent Thickets Constrain the US Biosimilars Market and Domestic Manufacturing,” was the top-read article on its...
MGA Report Featured by The Center for Biosimilars
MGA Report Featured by The Center for Biosimilars On Thursday, The Center for Biosimilars, a sister site of The American Journal of Managed Care, published an article discussing the differences between the patent systems in the United States and Europe when it comes...
New White Paper Identifies Patent Thickets as Barrier to US Biosimilars Market and Domestic Manufacturing
New White Paper Identifies Patent Thickets as Barrier to US Biosimilars Market and Domestic Manufacturing Alex Brill and Christy Robinson | Washington, DC The white paper offers policy options to improve access to affordable biosimilar medicines. WASHINGTON,...
Shared Savings Models Could Yield Part B Savings
Shared Savings Models Could Yield Part B Savings Skylar Jeremias | The Center for Biosimilars “The establishment of a shared savings model has the potential to increase health care savings, biologic competition, and biosimilar utilization if implemented in...- Do Tax Cuts Cause Inflation? Alex Brill on ‘The Price of Business’
- ‘The Price of Business’: Alex Brill Talks Rising Inflation
- Massachusetts’s Proposed ‘Millionaires’ Tax’ Will Push up the Federal Deficit
- Charitable Giving is Good. Be Smart About how to Encourage It.
- MGA Report Cited in Forbes Article on Rising Prescription Drug Prices
- New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition
- The Great Resignation: Alex Brill Shares Insights on i24News
- Patent Thickets Constrain US Biosimilars Market
- Alex Brill Talks Rising Inflation and Corporate Taxes on CNBC’s ‘Squawk Box’
- IAM Quotes MGA Report in Article Discussing the Problem of Patent Thickets
